GSK-1904529A 1 mg | ≥98% LKT Laboratories, Inc. InsR and IGF-1R inhibitor. More Information Supplier Page × GSK-1904529A
I-BET151 25 mg | ≥98% LKT Laboratories, Inc. BRD2/3/4 inhibitor. More Information Supplier Page × I-BET151
I-BET151 10 mg | ≥98% LKT Laboratories, Inc. BRD2/3/4 inhibitor. More Information Supplier Page × I-BET151
I-BET151 50 mg | ≥98% LKT Laboratories, Inc. BRD2/3/4 inhibitor. More Information Supplier Page × I-BET151
E64 100 mg | ≥98% LKT Laboratories, Inc. Cysteine protease inhibitor. More Information Supplier Page × E64
GSK-1838705A 25 mg | ≥98% LKT Laboratories, Inc. ALK and IGF-1R inhibitor. More Information Supplier Page × GSK-1838705A
Foretinib 5 mg | ≥98% LKT Laboratories, Inc. ROS1, MET, Ron, Axl, TIE-2, VEGFR2 inhibitor. More Information Supplier Page × Foretinib
Flibanserin 50 mg | ≥98% LKT Laboratories, Inc. 5-HT1A agonist, 5-HT2A antagonist. More Information Supplier Page × Flibanserin
